Hot Features
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologi... Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company’s lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.15 | 3.94782011672 | 29.13 | 30.5 | 27.18 | 137872 | 28.78515578 | CS |
| 4 | 1.02 | 3.48598769651 | 29.26 | 32.255 | 26.91 | 186276 | 28.91564497 | CS |
| 12 | -0.47 | -1.52845528455 | 30.75 | 32.27 | 26.3112 | 203484 | 28.99149306 | CS |
| 26 | 10.82 | 55.6012332991 | 19.46 | 36.03 | 16.77 | 306758 | 25.08896853 | CS |
| 52 | 7.33 | 31.9389978214 | 22.95 | 36.03 | 14.385 | 358487 | 21.22495397 | CS |
| 156 | 13.38 | 79.1715976331 | 16.9 | 61.07 | 13.7 | 267056 | 24.89740769 | CS |
| 260 | 13.38 | 79.1715976331 | 16.9 | 61.07 | 13.7 | 267056 | 24.89740769 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.